Kephera Diagnostics awarded Phase II grant from the National Institute of Allergy and Infectious Diseases (NAID) for Zika virus test

Kephera Diagnostics awarded Phase II grant from the National Institute of Allergy and Infectious Diseases (NAID) for Zika virus test Framingham, MA – July 23, 2020. Kephera Diagnostics announced today that it has been awarded a two-year, $1,989,300 Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Allergy and Infectious Diseases…

Kephera seeks volunteers who are confirmed COVID-19 positive to donate finger prick blood samples to help develop a new COVID-19 antibody test.

Kephera seeks volunteers who are confirmed COVID-19 positive to donate finger prick blood samples to help develop a new COVID-19 antibody test. Framingham, MA, April 24, 2020…….Kephera Diagnostics has launched a new study aimed at collecting blood samples from  volunteers at least 18 years of age who have been confirmed positive for COVID-19, for use…

NIAID awards grant to Kephera Diagnostics for point-of-care test for Neurocysticercosis

NIAID awards grant to Kephera Diagnostics for point-of-care test for Neurocysticercosis Framingham, MA – January 13, 2020.  Kephera Diagnostics has been awarded a two-year, $600,000 Phase I SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a point-of-care test for Neurocysticercosis, the company announced today.  Neurocysticercosis is an infection of…

Kephera Diagnostics awarded contract from the National Cancer Institute for development of a test for parasite linked to a rare cancer

Kephera Diagnostics awarded contract from the National Cancer Institute for development of a test for parasite linked to a rare cancer The National Cancer Institute, an agency of the National Institutes of Health, has awarded a Phase I Small Business Innovative Research (SBIR) contract to Kephera Diagnostics (Framingham, MA) for $299,997 to develop a test for liver…

National Institutes of Health awards grant for novel test-of-cure for Chagas disease

National Institutes of Health awards grant for novel test-of-cure for Chagas disease Framingham, MA – July 16, 2019.  The National Institute of Allergy and Infectious Diseases, an agency of the National Institutes of Health (NIH), has awarded a two-year, $594,008 Small Business Innovative Research (SBIR) grant to Kephera Diagnostics to develop a test-of-cure for Chagas…

National Institutes of Health awards grant to Kephera Diagnostics for new point-of-care test for Chagas disease

Framingham, MA – September 18, 2018.  The National Institute of Allergy and Infectious Diseases, an agency of the National Institutes of Health (NIH), has awarded a two-year, $599,316 SBIR grant to Kephera Diagnostics to develop a new test for Chagas disease, the company announced today.  Under the SBIR grant program, this Phase I grant is…